Hepatitis G virus and related flaviviruses: Pathogens or passengers?

Current Clinical Topics in Infectious Diseases

Volumn , Issue 18, 1998, Pages 274-285

  He, Xiaosong ^a   Robinson, William S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLASSIFICATION; FLAVIVIRUS; HUMAN; PHYSIOLOGY; REVIEW; VIROLOGY; VIRUS HEPATITIS; VIRUS INFECTION;

FLAVIVIRIDAE; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; HEPATITIS, VIRAL, HUMAN; HUMANS;

EID: 0031608760     PISSN: 01953842     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (43)

1. Choo Q-L, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B hepatitis genome. Science 1989;244:352-362.
2. Alter HJ, Bradley DW. non-A, non-B hepatitis unrelated to the hepatitis C virus (non-ABC). Sem Liv Dis 1995;15:110-120.
3. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic Non-A, Non-B Hepatitis Study Team. N Engl J Med 1992;327: 1899-1905.
4. Alter HJ. Post-transfusion hepatitis in the United States. In: Nishioka K, Suzuki H, Mishiro S, et al, eds. Viral hepatitis and liver disease. Tokyo: Springer-Verlag, 1994:551-553.
5. Simons JN, Pilot-Matias TJ, Leary TP, et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 1995;92:3401-3405.
6. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995;1: 564-569.
7. Linnen J, Wages J Jr, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-508.
8. Deinhardt F, Holmes AW, Capps RB, et al. Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions. J Exp Med 1967;125;673-688.
9. Parks WP, MeInick JL. Attempted isolation of hepatitis viruses in marmosets. J Infect Dis 1969;120:539-547.
10. Deinhardt F, Peterson D, Cross G, et al. Hepatitis in marmosets. Am J Med Sci 1975; 270:73-80.
11. Whittington RO, Decker RH, Ling C-M, et al. Comparison of infectivity of human non-A/non-B hepatitis and the GB hepatitis agent in marmosets. Monogr Primatol 1983;2:221-224.
12. Karayiannis P, Petrovic LM, Fry M, et al. Studies of GB hepatitis agent in tamarins. Hepatology 1989;9:186-192.
13. Lisitsyn N, Lisitsyn N, Wigler M. Cloning the differences between two complex genomes. Science 1993;259:946-951.
14. Bukh K, Apgar C, Purcell RH. Natural history of GBV-A and GBV-B agents in animal models: discovery of two new variants of GBV-A. In: International Symposium on Viral Hepatitis and Liver Disease. Rome, 1996:40.
15. Alter HJ. The cloning and clinical implications of HGV and HGBV-C. N Engl J Med 1996;334:1536-1537.
16. Reyes GR, Kim JP. Sequence-independent, single-primer amplification (SISPA) of complex DNA populations. Mol Cell Probes 1991; 5:473-481.
17. Murphy FA. Virus taxonomy. In: Fields BN, Knipe DM, Howley PM, eds. Fundamental virology. 3rd ed. New York: Lippincott-Raven, 1996:15-57.
18. Leary TP, Muerhoff AF, Simons JN, et al. Sequence and genomic organization of GBV-C: a novel member of the Flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996;48:60-67.
19. Kim J, Linnen J, Wages J, et al. Molecular cloning and characterization of hepatitis G virus (HGV). In: Proceedings of the IX International Symposium on Viral Hepatitis and Liver Disease. Rome, 1996:34.
20. Hess G, Kim J, Karayiannis P, et al. The interaction of HCV with HGV. In: Proceedings of the IX International Symposium on Viral Hepatitis and Liver Disease. Rome, 1996:35.
21. Mishiro S, Okamoto H. New HCV-like agent: epidemiology in Japan and characterization of the viral genome. In: Proceedings of the IX International Symposium on Viral Hepatitis and Liver Disease. Rome, 1996:34.
22. Farci P, Alter HJ, Govindarajan S, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992;258:135-140.
23. Choo QL, Kuo G, Ralston R, et al. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci USA 1994;91:1294-1298.
24. Krawczynski K, Gallagher M, Spelbring J, et al. Experimental HGV infection in primates. In: Proceedings of the IX International Symposium on Viral Hepatitis and Liver Disease. Rome, 1996:39.
25. Alter HJ, Nakatsuji Y, Shih JW-K, et al. Transfusion-associated hepatitis G virus infection. In: Proceedings of the IX International Symposium on Viral Hepatitis and Liver Disease. Rome, 1996:34.
26. Aikawa T, Sugai V, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med 1996;334:196-197.
27. Kekule AS, Nitschko H, Froesner G, et al. Hepatitis GB virus: coinfection with HCV, response to interferon and possible association with fulminant hepatitis. In: Proceedings of the IX International Symposium on Viral Hepatitis and Liver Disease. Rome, 1996:40.
28. Schmidt B, Korn K, Fleckenstein B. Molecular evidence for transmission of hepatitis G virus by blood transfusion. Lancet 1996;347: 909.
29. Moaven LD, Tennakoon PS, Bowden DS, et al. Mother-to-baby transmission of hepatitis G virus. Med J Austr 1996;165:84-85.
30. Feucht HH, Zollner B, Polywka S, et al. Vertical transmission of hepatitis G. Lancet 1996;347:615-616.
31. De Lamballerie X, Charrel RN, Dussol B. Hepatitis GB virus C in patients on hemodialysis. N Engl J Med 1996;334:1549.
32. Alter M, Gallagher M, Morris T, et al. Epidemiology of non A-non E hepatitis. In: Proceedings of the IX International Symposium on Viral Hepatitis and Liver Disease. Rome, 1996:34.
33. Eleftheriou A, Ruedinger B, Angastiniotis M, et al. Non-ABCE hepatitis among thalassemia major patients and blood donors residing in Cyprus. In: Proceedings of the IX International Symposium on Viral Hepatitis and Liver Disease. Rome, 1996:39.
34. Wang J-T, Tsai F-C, Lee C-Z, et al. A prospective study of transfusion-transmitted GB virus C infection: similar frequency but different clinical presentation compared with hepatitis C virus. In: Proceedings of the IX International Symposium on Viral Hepatitis and Liver Disease. Rome, 1996:39.
35. Nuebling CM, Lower J. GB-C genomes in a high-risk group, in plasma pools, and intravenous immunoglobulin. Lancet 1996;347:68.
36. Masuko K, Mitsui T, Iwano K, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996;334: 1485-1490.
37. Primi D. Identification of new hepatitis viruses in the Italian population. In: Proceedings of the IX International Symposium on Viral Hepatitis and Liver Disease. Rome, 1996:40.
38. Thomas HC, Karaylannis P, Hadzlyiannis S, et al. Clinical significance of HGV infection in Europe. In: Proceedings of the IX International Symposium on Viral Hepatitis and Liver Disease. Rome, 1996:35.
39. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995;346:1131-1132.
40. Kuroki T, Nishiguchi S, Tanaka M, et al. Does GBV-C cause fulminant hepatitis in Japan? Lancet 1996;347:908.
41. Sallie R, Shaw J, Mutimer D. GBV-C virus and fulminant hepatic failure. Lancet 1996; 347:1552.
42. Chemin I, Vermot-Desroches C, Baginski I, et al. Selective detection of human hepatitis B virus surface and core antigens in peripheral blood mononuclear cell subsets by flow cytometry. J Viral Hepatitis 1994;1:39-44.
43. Luppi M, Torelli G. The new lymphotropic herpesviruses (HHV-6, HHV-7, HHV-8) and hepatitis C virus (HCV) in human lymphoproliferative diseases: an overview. Haematologica 1996;81:265-281.